Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antibiotics for Latency in Previable PPROM
NCT04047849Phase 4Recruiting
- Sponsor
- Woman's
- Start
- Aug 2019
- Primary completion
- Jul 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of azithromycin, amoxicillin in preterm premature rupture of membranes (pPROM), sponsored by Woman's. Started Aug 2019; status: recruiting.
02
Drugs
azithromycinamoxicillin
03
Conditions
preterm premature rupture of membranes (pPROM)
Beyond the preview
Go deeper on NCT04047849.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04047849.